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Cytokines are critical mediators of inflammation and host defense. Cytokine production is 
regulated during transcription and post-transcription. Post-transcriptional regulation modifies 
mRNA stability and translation, allowing for the rapid and flexible control of gene expression, 
which is important for coordinating the initiation and resolution of inflammation. We review 
here a variety of post-transcriptional control mechanisms that regulate inflammation and discuss 























Inflammation is an essential component of the immune responses that allows multicellular 
organisms to remove detrimental stimuli and repair tissue damage. Causes of inflammation 
include various factors such as microbial infection, tissue injury and cellular stress. 
Inflammation is classically characterized by five symptoms: redness, swelling, heat, pain, and 
loss of tissue function. Inflammatory responses are rapidly elicited in response to infection with 
various pathogens or cellular stimuli (Lawrence et al., 2002). Proinflammatory cytokines such 
as tumor necrosis factor (TNF), interleukin-1β (IL-1β) and IL-6 mediate inflammation. In 
resting cells of the innate immune system the expression of cytokines is suppressed, only being 
induced rapidly in response to infection by pathogens via a set of pattern-recognition receptors 
(PRRs) such as Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and Nod-like receptors 
(NLRs) (Takeuchi and Akira, 2010; Beutler, 2009; Medzhitov and Horng, 2009). PRRs 
recognize molecular structures that are broadly shared by pathogens, known as 
pathogen-associated molecular patterns (PAMPs), such as bacterial lipopolysaccharide (LPS) 
(Janeway, 1989; Akira et al., 2006). Upon PAMP recognition, PRRs initiate a series of signaling 
pathways that lead to the activation of transcription factors, including NF-κB, activator protein 
1 (AP-1), interferon (IFN)-regulatory factors (IRFs), and CCAAT/enhancer-binding protein β 
(C/EBPβ). In addition to eliciting inflammation, PRR signaling simultaneously induces 
maturation of dendritic cells (DCs), which are responsible for stimulating the second line of host 
defense, adaptive immunity. 
 Activated transcription factors transcribe a family of mRNAs encoding 
proinflammatory cytokines that are translated to proteins, resulting in the secretion of cytokines. 
Once a factor causing inflammation has been neutralized, the cytokine-mediated inflammatory 
response is rapidly terminated and damaged tissues are repaired. However, overproduction of 
cytokines (cytokine storm) by immune cells to overwhelm pathogens can be fatal. A cytokine 
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storm can also be caused by noninfectious disorders such as graft-versus-host disease (GVHD). 
Inflammatory responses are also critical for the pathogenesis of autoimmune diseases 
(Marshak-Rothstein, 2006). 
 The expression of cytokines and pro-inflammatory factors is tightly regulated at 
multiple levels, including gene transcription, mRNA translation, and mRNA degradation 
(Stoecklin et al., 2006). Transcriptional regulation has been characterized and shown to control 
the expression of cytokines. Although transcription is the essential first step in the regulation of 
gene expression, it is a complicated process that cannot be rapidly stopped or redirected. These 
regulatory pathways are tightly controlled by multiple biological networks, in particular, 
post-transcriptional regulation, which determines the fate of mRNA in association with 
RNA-binding proteins (RBPs) such as tristetraprolin (TTP), ARE/poly-(U) binding degradation 
factor 1 (AUF1), ZCCHC11, and Regnase-1 (also known as Zc3h12a, Mcpip1) (Anderson, 
2010; Palanisamy et al., 2012). In addition to RBPs, microRNAs (miRNAs) are important 
regulators of gene expression in the immune system through cooperation with RBPs. 
Post-transcriptional regulation controls mRNA stability and translation and can rapidly repress 
protein expression despite on-going gene transcription. Thus, given its ability to rapidly control 
gene expression, post-transcriptional dampening of protein expression can actively promote the 
resolution of inflammation to prevent unintended tissue damage (Stoecklin and Anderson, 2006). 
In this way, post-transcriptional control mechanisms link the initiation phase and the resolution 
phase of inflammation. Most post-transcriptional control mechanisms target the 3′-untranslated 
region (3′-UTR) of mRNAs to repress expression of the target transcript (Anderson, 2008; von 
Roretz and Gallouzi, 2008; Shyu et al., 2008). In this review, we focus on post-transcriptional 
regulation mechanisms that regulate mRNA stability and modulate both the initiation and 
resolution of inflammation. We also discuss how different types of post-transcriptional control 




AU-rich Elements (AREs) are Critical in the Regulation of Cytokine mRNA Stability 
 
The regulation of mRNA stability and translation is important for the control of gene expression, 
and is determined by cis-acting sequences in the 3′-UTRs that promote mRNA degradation and 
suppress mRNA translation. A well-characterized motif present within the 3′-UTR of mRNA is 
the adenine- and uridine-rich element (ARE). Clusters of AREs found in mRNAs encoding 
cytokines were first identified over 25 years ago (Caput et al., 1986) and subsequent studies 
showed that cytokines, chemokines, lymphocytes, proto-oncogenes, and pro-inflammatory 
genes are subject to ARE-mediated decay (Shaw and Kamen, 1986; Hamilton et al., 2007). 
AREs provide binding sites for trans-acting RBPs, such as TTP, AUF1, and HuR (embryonic 
lethal abnormal vision system human homologue 1 (ELAV1)), that subsequently regulate the 
stability and translation of mRNA. ARE basic motifs include pentamers of AUUUA, nonamers 
of UUAUUUAUU, and AU-rich clusters composed of linked pentamers and/or nonamers 
(Wilusz et al., 2001). Bakheet et al. created a database of human ARE mRNAs (ARED; 
http://brp.kfshrc.edu.sa/ARED/) based on the patterns of AUUUA motifs (Bakheet et al., 2006) 
demonstrating approximately 8% of mRNAs within the human genome contain AREs. AREs 
are located at the 3′-UTR of mRNA transcripts for cytokines such as granulocyte-macrophage 
colony-stimulating factor (GM-CSF), TNF, IL-2, IL-3, IL-6, and IL-8, as well as 
pro-inflammatory factors like cyclooxygenase 2 (COX-2) (Figure 1). mRNAs harboring AREs 
are prone to quick degradation in innate immune cells in general, although stimulation with LPS 
can extend their half-life (Hao and Baltimore, 2009). Thus, AREs are critical elements in 
controlling gene expression at the post-transcriptional level. 
 
 
Interaction of Cytokine mRNAs with RNA Binding Proteins 
 
Cytokine mRNA expression is restricted in resting cells through continuously active mRNA 
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decay mechanisms. Induction of mRNA decay pathways allow attenuation of cytokine 
production through interactions with RBPs (Anderson, 2009). AREs in 3′-UTR of mRNAs 
promote binding of RBPs that degrade or stabilize mRNA transcripts, often in association with 
other proteins. Several studies have identified RBPs that can bind to AREs and regulate mRNA 
stability and translation, including TTP and AUF1. Cytokine mRNAs and their functional 
interactions with important RBPs are summarized in Table 1. A detailed description of each 





Tristetraprolin is a well-characterized zinc-finger protein that regulates immune functions 
(Sanduja et al., 2011). TTP transcription is induced by inflammatory modulators such as TNF, 
LPS (Chen et al., 2006), glucocorticoids (Smoak and Cidlowski, 2006), insulin (Cao et al., 
2008), and IFN-γ (Sauer et al., 2006). TTP-deficient mice develop arthritis, dermatitis, and 
cachexia, a syndrome caused by the spontaneous overexpression of pro-inflammatory cytokines, 
particularly TNF (Taylor et al. 1996; Carballo and Blackshear, 2001) suggesting TTP is 
involved in the damping of inflammation. Treatment of these mice with TNF-specific antibodies 
reversed almost all pathology, implicating dysregulated cytokine expression as a principal cause 
of this phenotype. Subsequent biochemical studies showed that TTP decreased TNF mRNA 
stability by binding to its ARE (Carballo et al., 1998). TTP harbors two Cys-Cys-Cys-His 
(CCCH)-type zinc-finger domains and associates with mRNA via AU-rich elements present in 
the 3′-UTR, leading to removal of the poly(A) tail by recruitment of a deadenylase (Carrick et 
al., 2004).  
Deadenylation promotes rapid mRNA degradation that is thought to occur during 
processing of (P)-bodies, small cytoplasmic foci that contain many enzymes required for mRNA 
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decay. Cells exposed to various stresses such as heat shock, oxidative stress, or glucose 
deprivation promote the assembly of stress granules, small cytoplasmic foci that harbor 
translationally arrested mRNAs, stalled translation initiation factors, and ARE-binding proteins 
such as T-cell-restricted intracellular antigen-1 (TIA-1) and TIA-1-related protein (TIAR) 
(Anderson and Kedersha, 2008). Under conditions of stress, TTP is recruited to stress granules 
(Murata et al., 2005; Kedersha et al., 2005), and facilitates delivery of selected mRNAs from 
stress granules to P-bodies for degradation, suggesting a TTP-dependent dynamic relationship 
between stress granules and P-bodies. TTP also destabilizes mRNA transcripts encoding 
multiple inflammatory modulators, including GM-CSF (Carballo et al., 2000), IL-2 (Ogilvie et 
al., 2005), IL-6 (Sauer et al., 2006), c-Fos (Chen et al., 2001), inducible nitric oxide synthase 
(iNOS) (Linker et al., 2005), COX-2 (also known as PTGS2) (Phillips et al., 2004), 
CC-chemokine ligand 2 (CCL2) (Sauer et al., 2006), CCL3 (Sauer et al., 2006), 
CXC-chemokine ligand 1 (CXCL1) (Datta et al., 2008), IFN-γ (Ogilvie et al., 2009), and IL-10 
(Stoecklin et al., 2008). Although the exact mechanism of cytoplasmic TTP-dependent mRNA 
turnover remains unclear, various models have been proposed, including targeting of mRNA to 
the P-body. Together, these studies demonstrate TTP is a key player in post-transcriptional gene 




ARE/poly-(U) Binding Degradation Factor 1 (AUF1, also known as hnRNP D) and 
Heterogeneous Nuclear Ribonucleoprotein U (hnRNP U) 
 
AUF1 (also known as heterogeneous nuclear ribonucleoprotein D, hnRNP D) is an established 
attenuator of inflammatory cytokine responses that acts by destabilizing inflammatory cytokine 
mRNAs, such as IL-2, TNF, and IL-1β, and other mRNAs containing AREs in 3′-UTRs (Lu et 
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al., 2006; Sadri and Schneider, 2009). AUF1 is an ARE-binding protein that consists of four 
highly related protein isoforms generated by alternate RNA splicing from a single genetic locus 
(Guhaniyogi and Brewer, 2001). The four AUF1 isoforms contain two RNA recognition motifs 
(RRMs) in the central portion of the protein (Wagner et al., 1998; Barker et al., 2012). Mice 
lacking AUF1 develop chronic dermatitis with increasing age characterized by pruritis and 
excoriations, which are associated with increased IL-2, TNF-α, and IL-1β (Sadri and Schneider, 
2009). Histological analysis of AUF1-deficient mice showed marked epidermal acanthosis and 
spongiosis, neovascularization, and elevated numbers of inflammatory cells, including T cells, 
macrophages, neutrophils, mast cells, and eosinophils. Although AUF1 is primarily localized in 
the nucleus, it shuttles to the cytoplasm and attaches to ARE-containing mRNAs through 
MAPK phosphatase-1 (MKP-1)-induced translocation (Yu et al., 2011). MKP-1 functions as a 
negative regulator of the host inflammatory response to infection by specific dephosphorylation 
of activated mitogen-activated protein kinases (MAPKs), which when activated induces 
pro-inflammatory cytokines. MKP-1 promotes translocation of AUF1 from the nucleus to the 
cytoplasm in response to LPS stimulation, resulting in destabilized cytokine mRNAs. Although 
the mechanisms underlying the regulation of cytokine mRNA stability by AUF1 have not been 
fully delineated, these findings show the complexity of the processes that control 
AUF1-regulated cytokine mRNA expression and cellular localization. 
 Recently, another member of the hnRNP family,, heterogeneous nuclear 
ribonucleoprotein U (hnRNP U), was shown to regulate TLR-induced proinflammatory cytokine 
production in macrophages (Zhao et al., 2012). Whereas AUF1 (hnRNP D) is principally 
associated with destabilization of proinflammatory cytokine mRNAs, hnRNP U stabilizes 
cytokine mRNAs such as TNF-α, IL-6, and IL-1β, but not IL-12. hnRNP U expression is 
induced by TLR signaling and binds to cytokine mRNAs through an Arg-Gly-Gly (RGG) 
domain. Moreover, TLR stimulation induces translocation of hnRNP U from the nucleus to the 
cytoplasm. These studies indicate that hnRNP proteins have different functions in the regulation 
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of proinflammatory cytokine production by either increasing or decreasing mRNA stabilization. 
However, the functional relationship between AUF1 (hnRNP D) and hnRNP U in the regulation 





In contrast to the normal role of zinc-finger proteins in dampening the expression of 
inflammatory mediators, the zinc-finger protein ZCCHC11 (also known as terminal 
uridylyltransferase 4) stabilizes mRNA encoding IL-6 (Jones et al., 2009). ZCCHC11 is a 
CCHC-type zinc-finger domain containing RNA-binding protein with a nucleotidyltransferase 
domain. ZCCHC11 has uridyltransferase activity and can add non-genome-encoded uridine 
residues to the 3′ ends of RNA (Jones et al., 2009). Targeted knockdown of ZCCHC11in the 
A549 human alveolar epithelial cell line inhibited TNF-induced secretion of IL-6, CCL5, 
transforming growth factor-β (TGF-β) and vascular endothelial growth factor A (VEGFA). 
Decreased expression of IL-6 was caused by increased decay of IL-6 mRNA transcripts, 
indicating that ZCCHC11 stabilizes IL-6 mRNA. A recent study found that ZCCHC11 adds 
terminal uridine to microRNA, miR-26, which target IL-6 mRNA (Jones et al., 2009). 
Uridylated miR-26 fails to repress IL-6 mRNA, and ZCCHC11 thereby potentiates IL-6 
production in response to TNF stimulation. Although this mechanism of post-transcriptional 
control provides new insight to the regulation of cytokine mRNA stability, it is unclear which 
other miRNAs are subject to uridine modification and how this process determines the levels of 
active miRNAs. Confirmation of this mechanism will provide further insight to 




Regulatory RNase-1 (Regnase-1, also known as Zc3h12a, Mcpip1) 
 
RNase Regnase-1 (also known as Zc3h12a, Mcpip1) is composed of a PilT-N terminal 
(PIN)-like RNase domain and a CCCH-type zinc-finger domain (Matsushita et al., 2009) and is 
critical in preventing autoimmunity by controlling the stability of mRNA encoding IL-6, 
IL-12p40, and Regnase-1 itself (Figure 2). The production of IL-6 and IL-12p40 in response to 
TLR ligands is greater in Regnase-1-deficient macrophages compared with normal macrophages 
(Matsushita et al., 2009). The decay of IL-6 mRNA is impaired in Regnase-1-deficient 
macrophages, as Regnase-1 destabilizes mRNA via a conserved element, but not AREs, present 
in the 3′-UTR of IL-6 mRNA. Regnase-1-deficient mice spontaneously develop severe 
autoimmune inflammatory disease, indicating Regnase-1-mediated control of mRNA expression 
has an essential role in maintaining homeostasis. 
 Although the expression of Regnase-1 mRNA is induced in response to stimulation 
with TLR ligands, Regnase-1 protein is expressed even in unstimulated macrophages, mouse 
embryonic fibroblasts (MEFs), thymus, spleen, lymph nodes, and lungs (Iwasaki et al., 2011). 
Regnase-1 protein is rapidly degraded in response to stimulation with IL-1β or TLR ligands but 
not TNF. Degradation of Regnase-1 protein is important for higher expression of IL-6 mRNA. 
Biological studies have shown that inhibitors of transcription factor NF-κB (IκB) kinase (IKK) 
complex (an enzyme involved in the activation of transcription factor NF-κB by 
phosphorylation and ubiquitin-proteasome-mediated degradation of NF-κB-inhibitory protein 
IκBα, and composed of IKKα, IKKβ, and IKKγ (NEMO) subunits) controls the stability of IL-6 
mRNA by phosphorylating Regnase-1 in response to stimulation via IL-1R or TLR. Regnase-1 
is phosphorylated by IKKα/β, and phosphorylated Regnase-1 undergoes 
ubiquitin-proteasome-mediated degradation via the E3 ligase β-TrCP complex (β-transducin 
repeat–containing protein; also known as FBW1). Regnase-1 is then re-expressed in IL-1R- or 
TLR-activated cells after a period of lower expression. Regnase-1 mRNA is negatively 
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regulated by Regnase-1 itself via a stem-loop region present in the Regnase-1 3′-UTR. These 
finding show that the IKK complex phosphorylates IκBα, thereby activating transcription, and 
Regnase-1, thereby releasing a ‘brake’ on IL-6 mRNA expression (Figure 2). Although it 
remains to be determined which cis-acting and trans-acting elements are responsible for specific 
Regnase-1-mediated mRNA destabilization, the regulatory mechanisms can suppress unwanted 
inflammation and rapid production of proinflammatory cytokines in response to infection. 
 
 
miRNA-Mediated Regulation of Cytokine Expression Levels 
 
miRNAs are a specific class of evolutionarily conserved small (19-25 nucleotides) endogenous 
non-coding RNAs that regulate gene expression at the post-transcriptional level (Rana, 2007). 
miRNAs use base-pairing to bind to partially or perfectly complementary sites in the 3′-UTR of 
mRNAs, to induce translational repression or mRNA degradation of the target gene (Rana, 
2007) (Table 2). Thus, miRNAs regulate diverse cellular and molecular processes, including 
cellular proliferation, differentiation, apoptosis and innate immunity (Rana, 2007; Friedman et 
al., 2009). Regulation of cytokine expression through the association of miRNAs with RBPs 
can fine-tune immune responses by a number of mechanisms including: (1) mRNA decay and 
translational inhibition through miRNA and RBP cooperation; (2) mRNA stabilization due to 
competition between RBPs and miRNAs; and (3) environmental effects on mRNA stability, 
mediated through miRNAs and RBPs. An early example of miRNA-assisted RBP regulation of 
cytokine mRNA was observed for TNF-α, where miR-16 had a partial sequence match with the 
TNF-α ARE and ARE-mediated decay of TNF-α was dependent on both TTP and miR-16 (Jing 
et al., 2005). Based on these data, it was hypothesized that miR-16-bound RNA-induced 
silencing complex (RISC) assisted TTP binding to ARE, which subsequently induced mRNA 
degradation by deadenylation. Recently, three miRNAs, miR-125b, miR-221, and miR-579, 
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were up-regulated during LPS-induced tolerance (a state that causes TNF-α mRNA to be 
degraded), and were capable of either associating with TTP to accelerate TNF-α mRNA decay 
or blocking TNF-α translation, possibly through recruitment of the translational inhibitor TIAR 
(El Gazzar and McCall, 2010). 
 Alternatively, HuR binding to c-Myc 3′-UTR repressed c-Myc expression by recruiting 
let-7/RISC to an adjacent site on the c-Myc 3′-UTR (Kim et al., 2011). HuR is an ARE-binding 
protein that modulates the expression of ARE-containing transcripts encoding immune 
modulators such as IL-4, TNF, IFN-γ, and COX-2. HuR is ubiquitously expressed in 
mammalian tissues, and although predominantly located in cell nuclei (>90% of the total), 
transient shuttling between nucleus and cytoplasm occurs (Barker et al., 2012). HuR contains 
three RRMs, with a long hinge region that includes a domain responsible for 
nuclear/cytoplasmic shuttling, separating the second and the third RRM. Phosphorylation of 
serine residues (S202 or S242) within this hinge region influences subcellular localization of 
HuR, leading to an accumulation of HuR in the nucleus. Domains 1 and 2 of RRM mediate 
recognition of U-rich target RNA sequences, whereas domain 3, originally implicated in binding 
poly-A tails of mRNAs, mediates 30-terminal adenosylation of non-polyadenylated RNA. 
Although HuR typically promotes mRNA expression for p21, proto-oncogene C-FOS, VEGF, 
MKP-1, iNOS, GM-CSF, sirtuin 1 (SIRT1), TNF-α, B-cell lymphoma-2 (Bcl-2), myeloid cell 
leukemia-1 (Mcl-1), COX-2, γ-glutamylcysteine synthetase heavy subunit (γ-GCSh), 
urokinase-type plasminogen activator (uPA) and its receptor (uPAR), p53, IL-3, and cyclins A2, 
B1, E1, and D1 (Abdelmohsen and Gorospe, 2010) through mRNA stabilization, HuR can 
interact with let-7 miRNA to repress the expression of c-Myc transcripts (Kim et al., 2011). 
 Conversely, RBPs and miRNAs can also compete with each another to promote 
mRNA stability. miR-4661, which contains a seed region that is complementary to ARE 
sequences, can up-regulate both IL-10 mRNA and protein levels upon transfection into 
LPS-stimulated RAW264.7 macrophages (Ma et al., 2010). Therefore, miR-4661 competes with 
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TTP for binding to ARE sequences in IL-10 mRNA, thus protecting the mRNA from 
TTP-mediated degradation. These studies show that ARE-binding proteins can interact with 





Post-transcriptional regulation is critical for inflammatory disease progression by controlling the 
production of cytokines, which activate multiple signaling cascades in inflammation, including 
extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), NF-κB, and p38 
MAPK. In most cases, post-transcriptional control mechanisms dampen the expression of 
inflammatory mediators by promoting mRNA decay or by inhibiting protein translation. These 
effects are mediated by regulatory factors that bind to cis-acting elements in 3′-UTRs of mRNA 
transcripts. The most common regulatory element is ARE. Loss of post-transcriptional 
regulation of cytokine mRNAs can dramatically increase cytokine production, leading to tissue 
destruction and increased mortality. Given the onset of cytokine production, several features of 
post-transcriptional control play a critical role in their maintenance. However, these mechanisms 
are complex and remain unclear. A greater understanding of how RBPs regulate mRNA stability 
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Figure 1: Schematic diagram of cytokine mRNA and sites of post-transcriptional 
regulation.  
Inflammatory cytokines are regulated post-transcriptionally through 5′- and 3′-UTRs. The 
5′-UTR dictates mRNA translation initiation, whereas the 3′-UTR regulates mRNA turnover. 
Cytokine mRNA stability and translation are highly regulated via their AU-rich elements 
(AREs). IL-6, TNF-α, and COX-2 AREs are underlined. 
 
Figure 2: Post-transcriptional regulation of IL-6 expression by Regnase-1. 
Regnase-1 destabilizes Il6 mRNA post-transcriptionally. In response to IL-1R or TLR 
stimulation, the IKK complex phosphorylates IκBα and Regnase-1, inducing ubiquitin 


















Cytokine mRNAs RNA-binding protein Regulation
IL-1β TTP mRNA destabilized
AUF1 mRNA destabilized
IL-2 TTP mRNA destabilized
NF90 mRNA stabilized
IL-3 TTP mRNA destabilized
IL-4 HuR mRNA stabilized
IL-6 Regnase-1 mRNA destabilized
TTP mRNA destabilized
AUF1 mRNA destabilized
IL-10 TTP mRNA destabilized
AUF1 mRNA destabilized
IL-12p40 Regnase-1 mRNA destabilized





GM-CSF TTP mRNA destabilized
IFNγ GAIT complex Translational repression
TTP mRNA destabilized
HuR mRNA stabilized














Cytokine mRNAs RNA-binding proteins miRNAs
TNFα TTP miR-16
TTP and TIAR miR-125, -221, or -579
FXR1 and AGO2 miR-369-3
IL-10 TTP miR-4661
VEGF hnRNP L miR-297, or -299
Table 2: Cooperative functions between RBPs and miRNAs in the 
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